SCHEMBL86467

SCHEMBL86467

COc1ccccc1CCCOc1ccc(CCC(N)(CO)CO)cc1C(F)(F)F

nearest known ligand 0.67

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 5/20 0.67
ABCB1 P08183 1/20 0.39
NR3C2 P08235 1/20 0.38
KCNH2 Q12809 1/20 0.38
TMEM97 Q5BJF2 1/20 0.38
SIGMAR1 Q99720 1/20 0.38
TNNC1 P63316 5/20 0.37
SGPL1 O95470 1/20 0.37
S1PR4 O95977 1/20 0.37
GPR183 P32249 1/20 0.37
CERS2 Q96G23 1/20 0.37
S1PR3 Q99500 1/20 0.37
S1PR5 Q9H228 1/20 0.37
FFAR1 O14842 1/20 0.37
FFAR4 Q5NUL3 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL80490 0.99 S1PR1 (0.66) S1PR1ABCB1NR3C2KCNH2TMEM97
SCHEMBL80754 0.90 S1PR1 (0.55) S1PR1ABCB1NR3C2KCNH2TMEM97
SCHEMBL80753 0.90 S1PR1 (0.55) S1PR1NR3C2S1PR4S1PR3S1PR5
SCHEMBL86234 0.89 S1PR1 (0.69) S1PR1NR3C2TNNC1SGPL1S1PR4
SCHEMBL86595 0.89 S1PR1 (0.55) S1PR1S1PR4S1PR3S1PR5
SCHEMBL86799 0.89 S1PR1 (0.69) S1PR1TNNC1SGPL1S1PR4GPR183
Hydrochloric Acid SCHEMBL81319 0.89 S1PR1 (0.68) S1PR1NR3C2TNNC1SGPL1S1PR4
SCHEMBL86117 0.88 S1PR1 (0.65) S1PR1TNNC1SGPL1S1PR4GPR183
Hydrochloric Acid SCHEMBL81484 0.88 S1PR1 (0.67) S1PR1NR3C2TNNC1SGPL1S1PR4
SCHEMBL86388 0.88 S1PR1 (0.67) S1PR1TNNC1SGPL1S1PR4GPR183

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8129361-B2 Amine compound and pharmaceutical use thereof MITSUBISHI TANABE PHARMA CORPORATION (JP) 2012-03-06 US disclosed
US-8129361-B2 Amine compound and pharmaceutical use thereof MITSUBISHI TANABE PHARMA CORPORATION (JP) 2012-03-06 US disclosed
US-20100179216-A1 AMINE COMPOUND AND PHARMACEUTICAL USE THEREOF MITSUBISHI TANABE PHARMA CORPORATION (JP) 2010-07-15 US disclosed
US-20100179216-A1 AMINE COMPOUND AND PHARMACEUTICAL USE THEREOF MITSUBISHI TANABE PHARMA CORPORATION (JP) 2010-07-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100179216-A1 AMINE COMPOUND AND PHARMACEUTICAL USE THEREOF HLA-B, HLA-A, HLA-C S1PR1 511/4885ABCB1 504/4885NR3C2 128/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.